DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹2,738 Cr | ₹1,653 Cr | ₹1,261 Cr | ₹2,459 Cr | ₹1,912 Cr |
What is the latest Cash Flow from Operating Activities ratio of DIVIS LABORATORIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹2,738 Cr |
| Mar2025 | ₹1,653 Cr |
| Mar2024 | ₹1,261 Cr |
| Mar2023 | ₹2,459 Cr |
| Mar2022 | ₹1,912 Cr |
How is Cash Flow from Operating Activities of DIVIS LABORATORIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,738 Cr | 65.64 | |
| Mar2025 | ₹1,653 Cr | 31.09 | |
| Mar2024 | ₹1,261 Cr | -48.72 | |
| Mar2023 | ₹2,459 Cr | 28.62 | |
| Mar2022 | ₹1,912 Cr | - | |
Compare Cash Flow from Operating Activities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹303,997.5 Cr | 11.5% | 20.6% | 68% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 3.9% | 7.8% | 13% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.9% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 1.1% | 7.9% | -6.3% | Stock Analytics | |
| MANKIND PHARMA | ₹108,837.0 Cr | 5.7% | 10.8% | 15.2% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 11.5% |
20.6% |
68% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses